<DOC>
	<DOCNO>NCT02818699</DOCNO>
	<brief_summary>The purpose clinical study determine effect safety long-term intake enzymatically modify isoquercitrin ( EMIQ ) , natural plant product body fat loss obese overweight individual .</brief_summary>
	<brief_title>Body Fat Reducing Effect Safety Enzymatically Modified Isoquercitrin Overweight Obese Subjects</brief_title>
	<detailed_description>This study conduct assess effect supplementation Enzymatically Modified Isoquercitrin ( EMIQ ) vs. placebo measure total body fat overweight obese adult . Participants visit HNRCA 5 different date . Visit 1 : Participants receive material instruction complete 24-hour dietary recall complete phone week prior next visit . Visit 2 : Overnight fast participant arrive Human Nutrition Research Center Aging ( HNRCA ) . Vital sign , EKG measure heart rhythm , scrub weight height obtain . Blood sample collect . Several baseline measurement perform visit include : lipid profile , insulin test , adiponectin , urine dip stick , skinfold thickness waist/hip circumference , rest metabolic rate ( RMR ) , DXA measure total body fat . A three factor eat questionnaire , food craving questionnaire , Stanford 7-Day Physical Activity Recall ( PAR ) administer assess volunteer 's dietary inhibition , restraint , hunger , craving physical activity level . EMIQ placebo capsule , compliance calendar , instruction dispense participant nursing staff . Visit 3 : Overnight fast participant arrive HNRCA four week last visit . Participants ask return unused supplement well compliance calendar . Vital sign , scrub weight change volunteer health , medication eligibility status assess . Blood sample collect . A second EKG perform . The PAR administer . Before next visit , participant complete 3 24- hour dietary recall phone . Visit 4 : overnight fast participant arrive HNRCA four week last visit . Participants ask return unused supplement well compliance calendar . Vital sign , scrub weight change volunteer health , medication eligibility status assess . Blood sample collect . The PAR administer . Before next visit , participant complete 3 24- hour dietary recall phone . Visit 5 : Overnight fast participant arrive HNRCA four week last visit . Vital sign scrub weight assess . Blood sample collect . Final measurement take visit include : routine health screen analysis , lipid profile , adiponectin , insulin test , urine dip stick , liver kidney function ( SGOT , SGPT , BUN , creatinine , calculate GFR ) , skin fold thickness , DXA , RMR waist/hip circumference . A three factor eat questionnaire , food craving questionnaire , PAR administer assess change volunteer 's dietary inhibition , restraint , hunger , craving activity level throughout study .</detailed_description>
	<mesh_term>Overweight</mesh_term>
	<criteria>Male female age 1865 year . Premenopausal female regular menstrual cycle postmenopausal female cessation menstrual cycle minimum 6 month . BMI range 28.035.0 Beck Depression Inventory Score less 20 . Fluency speak write English . Willingness randomize take EMIQ placebo . Must weigh least 164lbs Any major illness condition may interfere study outcome discretion study physician . Diabetes Type I &amp; Type II , use pharmacological treatment diabetes . Use medication interfere energy metabolism Receiving hormone therapy growth hormone , testosterone , estrogen exception hormone contraceptive . GI diseases , condition medication know influence GI absorption include active peptic ulcer disease inflammatory bowel disease ulcerative colitis , Crohn 's disease , celiac disease , chronic diarrhea constipation . Undergone gastric bypass bariatric weight loss procedure . Lipid lower medication : bile acid sequestrants ( Cholestyramine , Colestipol , Colesevelam , etc . ) , cholesterol absorption inhibitor ( EzetimibeZetia ) , fibrates ( Gemfibrozil , Clofibrate , Fenofibrate , Triclor ) . Exceptions exclusion 3hydroxy3methylglutarylcoenzyme A reductase ( HMGCoA reductase Statins ) . On plan participate weight loss program . Weight loss weight gain great 10 lb past 6 month . History eat disorder , anorexia , bulimia , bingeeating past 5 year . Participation regular endurance exercise : running , bike aerobics ( except walk ) great 2.5 hour per week , resistance training great per week . Regular use acid lower medication ( great 3 time per week ) antacid , proton pump inhibitor ( PPIs ) , H2 blocker . Unstable thyroid disease . Psychiatric disorder include schizophrenia , bipolar , major depression psychosis . Antidepressant medication : selective serotonin reuptake inhibitor ( SSRIs ) , serotonin norepinephrine reuptake inhibitor ( SNRIs ) , monoamine oxidase ( MAO ) inhibitor , tricyclic antidepressant ( TCAs ) . Cancer type ( except nonmelanoma skin ) past 5 year . Use chemotherapeutic agent . Pregnancy , plan become pregnant study period , breastfeed . Unwilling use effective birth control study . History bilateral mastectomy nodal dissection . Alcohol use , average , great 3 serving per day , 20 serving per week ( Serving size : 12oz beer , 4oz wine , 2oz hard liquor ) , selfreported binge drinking . Uncontrolled hypertension ( HTN ) determine discretion study MD register nurse ( RN ) . HTN medication allow study : angiotensin convert enzyme ( ACE ) inhibitor , calcium channel blocker , diuretic . Medications chronic obstructive pulmonary disease ( COPD ) kidney disease . αadrenergic βadrenergic blocker ( oral ocular ) diuretic . Renal chronic kidney disease due condition , renovascular disease , dialysis . Chronic liver disease hepatitis B , hepatitis C , cirrhosis . Cardiovascular disease include : myocardial infarction , cerebrovascular disease ( CVA ) , coronary artery bypass graft , stenosis great 50 % , angina , coronary artery disease ( CAD ) , congestive heart failure ( CHF ) , peripheral vascular disease ( PVD ) dysautonomia . History autoimmune disease rheumatoid arthritis , lupus , multiple sclerosis , vitiligo , psoriasis . HIV AIDS base selfreport . Steroid use exception overthecounter topical nasal steroid Flonase . Allergy medication regular antihistamine use . Seizure disorder . Acceptable managed medication free seizure activity 5 year . Smoking use nicotine replacement product past 6 month . Use dietary supplement contain vitamin ( except Calcium Vitamin D ) , mineral , herbal plantbased preparation , fish oil homeopathic remedy study participation unless willing discontinue prior enrollment . Current participation another research study . NonEnglish speaking . No social security number . Participation another research study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>